Companion and Complementary Diagnostics:From Biomarker Discovery to Clinical Implementation

图书简介

Companion and Complementary Diagnostics: From Biomarker Discovery to Clinical Implementation provides readers with in-depth insights into the individual steps in the development of companion diagnostic assays, from the early biomarker discovery phase straight through to final regulatory approval. Further, the clinical implementation of companion diagnostic testing in the clinic is also discussed. As the development of predictive or selective biomarker assays linked to specific drugs is substantially increasing, this book offers comprehensive information on this quickly-evolving area of biomedicine. It is an essential resource for those in academic institutions, hospitals and pharma, and biotech and diagnostic commercial companies.

1. Foreword 2. An Introduction to Companion and Complementary Diagnostics 3. The Drug-Diagnostic Co-Development Model 4. Systems Biology and Biomarker Development in Cancer Signaling Therapy 5. Immunohistochemistry 6. In Situ Hybridization 7. Polymerase Chain Reaction 8. Next Gen Sequencing Based Companion Diagnostics: From Biomarker Discovery to Clinical Implementation 9. Current Next Generation Sequencing Based Companion Diagnostics and their Analytical Validation 10. Companion and Complementary Diagnostics by Mass Spectrometry 11. Molecular Imaging Companion Diagnostics 12. Circulating Tumor DNA Analysis and Opportunities for Personalized Cancer Medicine 13. Companion Diagnostics Assay Development - Prototype, Verification and Analytical Validation 14. Tissue is the Issue: Challenges in Oncology Clinical Trial Tissue Sample Collection for Biomarker Analyses and Companion Diagnostics 15. Adaptive Trial Designs for Biomarker Driven Clinical Trials with Quantitative and Multiple Candidate Biomarkers 16. Companion Diagnostics Based on Time to Event Data 17. Regulatory Requirements for Companion Diagnostics and Drug-Diagnostic Co-Development in the United States of America 18. Companion Diagnostics and Biomarker Tests in the European Medicines Agency’s Assessment of Medicinal Products 19. Understanding the Current Regulatory Landscape for Companion Diagnostic Products in China 20. Regulatory requirements for companion diagnostics - Japan 21. Economic Evaluation of Companion and Complementary Diagnostics 22. A Risk Based Paradigm of Biomarkers in Clinical Trials 23. Implementing Companion Diagnostic Testing in the Clinic 24. Osimertinib (TAGRISSO) and the cobas EGFR Mutation Test v2 25. QMS Omecamtiv Mecarbil Immunoassay and Omecamtiv Mecarbil Co-Development 26. Current Status and Future Direction of Companion Diagnostics

Trade Policy 买家须知

关于产品：
● 正版保障：本网站隶属于中国国际图书贸易集团公司，确保所有图书都是100%正版。
● 环保纸张：进口图书大多使用的都是环保轻型张，颜色偏黄，重量比较轻。
● 毛边版：即书翻页的地方，故意做成了参差不齐的样子，一般为精装版，更具收藏价值。
关于退换货：
由于预订产品的特殊性，采购订单正式发订后，买方不得无故取消全部或部分产品的订购。
由于进口图书的特殊性，发生以下情况的，请直接拒收货物，由快递返回：
● 外包装破损/发错货/少发货/图书外观破损/图书配件不全（例如：光盘等）
并请在工作日通过电话400-008-1110联系我们。
签收后，如发生以下情况，请在签收后的5个工作日内联系客服办理退换货：
● 缺页/错页/错印/脱线
关于发货时间：
一般情况下：
●【现货】下单后48小时内由北京（库房）发出快递。
●【预订】【预售】下单后国外发货，到货时间预计5-8周左右，店铺默认中通快递，如需顺丰快递邮费到付。
● 需要开具发票的客户，发货时间可能在上述基础上再延后1-2个工作日（紧急发票需求，请联系010-68433105/3213）；
● 如遇其他特殊原因，对发货时间有影响的，我们会第一时间在网站公告，敬请留意。
关于到货时间：
由于进口图书入境入库后，都是委托第三方快递发货，所以我们只能保证在规定时间内发出，但无法为您保证确切的到货时间。
● 主要城市一般2-4天
● 偏远地区一般4-7天
关于接听咨询电话的时间：
010-68433105/3213正常接听咨询电话的时间为：周一至周五上午8：30～下午5：00，周六、日及法定节假日休息，将无法接听来电，敬请谅解。
其它时间您也可以通过邮件联系我们：customer@readgo.cn,工作日会优先处理。
关于快递：
● 已付款订单：主要由中通、宅急送负责派送，订单进度查询请拨打010-68433105/3213。

Companion and Complementary Diagnostics:From Biomarker Discovery to Clinical Implementation 伴随和互补诊断：从生物标志物发现到临床实施 遗传学

Companion and Complementary Diagnostics:From Biomarker Discovery to Clinical Implementation

伴随和互补诊断：从生物标志物发现到临床实施
遗传学